Xianglong Kong
- Cancer Research top 10%
- MicroRNA in disease regulation 2
-
- Lung Cancer Diagnosis and Treatment 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Pleural and Pulmonary Diseases 2
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Gastroesophageal reflux and treatments 2
-
- Congenital Diaphragmatic Hernia Studies 2
-
- Advancements in Battery Materials 2
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Xianglong Kong
23 papers receiving 581 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Cancer Research 281
- Molecular Biology 419
- Pulmonary and Respiratory Medicine 91
- Immunology 52
- Nephrology 17
Countries citing papers authored by Xianglong Kong
This map shows the geographic impact of Xianglong Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglong Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglong Kong more than expected).
Fields of papers citing papers by Xianglong Kong
This network shows the impact of papers produced by Xianglong Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglong Kong. The network helps show where Xianglong Kong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianglong Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 28 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 20 | |
| 13 | 2022 | 31 | |
| 14 | 2021 | 21 | |
| 15 | 2020 | 5 | |
| 16 | 2020 | 14 | |
| 17 | circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinomabreakdown → | 2020 | 305 |
| 18 | 2018 | 16 | |
| 19 | 2018 | 38 | |
| 20 | 2017 | 37 |
About Xianglong Kong
Xianglong Kong is a scholar working on Gastroenterology, Energy Engineering and Power Technology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 588 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Gastroesophageal reflux and treatments (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Pleural and Pulmonary Diseases (2 papers), Congenital Diaphragmatic Hernia Studies (2 papers), Advancements in Battery Materials (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (281 citations), Molecular Biology (419 citations) and Pulmonary and Respiratory Medicine (91 citations). Xianglong Kong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yubo Yan, Jianlong Bu, Shidong Xu, Xuhai Zhao, Mengfeng Liu, Fenghai Ren, Junfeng Wang, Dawei Sun, Hong Luo and Zhiguo Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.